Regulatory Gateway Neucomed serves as a gateway to the European market by providing CE marking support, acting as an authorized representative and distributor, and liaising with competent authorities and notified bodies, creating a ready-made entry point for global medical device manufacturers seeking EU access and regulatory streamlining.

European Distribution The company leverages an extensive European distribution network and direct affiliates, offering partners fast market access and localized channel execution across the DACH region and beyond.

Market Focus With a focus on epilepsy, heart failure, and structural heart diseases, Neucomed targets high-need patient segments and hospital systems, presenting opportunities for device partnerships or co-development in active therapeutic areas.

Group Synergies As part of the GENAERO Group with multiple brands and offices across Europe, the USA, and Asia, Neucomed benefits from cross-brand capabilities and a broad geographic footprint that can support multi-market deployments and scaled partnerships.

Growth Potential Current revenue is in the 0-1M range, indicating a smaller but high-growth potential platform; aligned with regulatory and distribution strengths, this signals significant upside for partners seeking European market access and expansion.